Mostrando 8 resultados de: 8
Filtros aplicados
Publisher
2007 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2007, Technical Proceedings(2)
ChemMedChem(2)
ACS Nano(1)
Handbook of Experimental Pharmacology(1)
Nano Today(1)
Área temáticas
Farmacología y terapéutica(7)
Enfermedades(5)
Medicina y salud(2)
Física aplicada(1)
Ingeniería civil(1)
Origen
scopus(8)
Engineering of targeted nanoparticles for cancer therapy using internalizing aptamers isolated by cell-uptake selection
ArticleAbstract: Figure Persented: One of the major challenges in the development of targeted nanoparticles (NPs) forPalabras claves:aptamer, in vitro selection, Internalization, Nanoparticles, targeted cancer therapyAutores:Chan J.M., Cheng J., Digga E., Farokhzad O.C., Frank Alexis, Langer R.S., Levy-Nissenbaum E., Lupták A., Shi J., Teply B.A., Xiao Z.Fuentes:scopusNanoparticle technologies for cancer therapy
ReviewAbstract: Nanoparticles as drug delivery systems enable unique approaches for cancer treatment. Over the lastPalabras claves:cancer therapy, drug delivery, Metastatic cancer, Nanoparticle, TargetedAutores:Farokhzad O.C., Frank Alexis, Langer R.S., Pridgen E.M.Fuentes:scopusNew frontiers in nanotechnology for cancer treatment
ReviewAbstract: Nanotechnology is a field of research at the crossroads of biology, chemistry, physics, engineering,Palabras claves:Cancer diagnosis, cancer therapy, Nanocarriers, Targeting moleculesAutores:Farokhzad O.C., Frank Alexis, Langer R.S., Radovic-Moreno A.F., Rhee J.W., Richie J.Fuentes:scopusHER-2-targeted nanoparticle-affibody bioconjugates for cancer therapy
ArticleAbstract: (Figure Presented) Affibodies are a class of polypeptide ligand that are potential candidates for tiPalabras claves:Affibodies, Antitumor agents, Nanoparticles, PLA-PEG copolymers, Targeted therapyAutores:Basto P.A., Farokhzad O.C., Frank Alexis, Levy-Nissenbaum E., Marein S.L., Molnar L.K., Pridgen E.M., Radovic-Moreno A.F., Wang A.Z., Westerhof K., Zhang L.Fuentes:scopusSuperparamagnetic iron oxide nanoparticle-aptamer bioconjugates for combined prostate cancer imaging and therapy
ArticleAbstract: (Chemical Equation Presented) Multifunctional superparamagnetic iron oxide nanoparticles: Herein wePalabras claves:doxorubicin, Nanoparticles, Superparamagnetic, TCL-SPIONAutores:Bagalkot V., Bander N.H., Cima M.J., Farokhzad O.C., Frank Alexis, Gu F.X., Jon S., Kantoff P.W., Langer R.S., Shaikh M., Vasilliou C.C., Wang A.Z., Yuet K., Zhang L.Fuentes:scopusTargeted aptamer-nanoparticles to diminish drug resistance of cancer cells in vitro study
Conference ObjectAbstract: Using prostate cancer as a model, we report the drug release of Docetaxel and doxorubicin from aptamPalabras claves:aptamer, doxorubicin, Poly (D,L-lactic-co-glycolic acid) (PLGA), Prostate cancer, Targeted deliveryAutores:Basto P.A., Farokhzad O.C., Frank Alexis, Langer R.S., Zhang L.Fuentes:scopusTargeted nanoparticle-polypeptide bioconjugates for breast cancer therapy
Conference ObjectAbstract: Novel approaches that allow for a more effective and less toxic chemotherapy for disseminated breastPalabras claves:Docetaxel, HER2, Pla, Poly (lactic acid), Targeted nanoparticlesAutores:Basto P.A., Farokhzad O.C., Frank Alexis, Gu F.X., Langer R.S., Levy-Nissenbaum E., Radovic-Moreno A.F.Fuentes:scopusTargeted nanoparticles for cancer therapy
ArticleAbstract: Over the past decade, there has been an increasing interest in using nanotechnology for cancer theraPalabras claves:Autores:Farokhzad O.C., Frank Alexis, Gu F.X., Hong S., Karnik R., Langer R.S., Levy-Nissenbaum E., Wang A.Z.Fuentes:scopus